Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

A hapten-specific chimaeric IgE antibody with human physiological effector function

Abstract

Immunoglobulin E (IgE; see ref. 1) has a central role in allergic reactions although it rarely exceeds 5 µg ml−1 even in the serum of severely allergic individuals. Both mast cells and basophils possess receptors which bind the Fc portion of IgE with high affinity; crosslinking of membrane-bound IgE by allergen results in degranulation of the cell and release of a variety of pharmacologically active mediators including histamine. Myeloma IgE has been successfully used to block the skin sensitizing activity of allergic sera2; however, human myeloma IgE is clearly in limited supply. The emergence of techniques allowing the stable introduction of immunoglobulin gene DNA into myeloma cells3–5 has allowed us to construct a mouse cell line that secretes a chimaeric IgE, λ1 antibody whose heavy chain is composed of a human Cε constant region fused to a mouse variable (VH) region. This chimaeric IgE is specific for the hapten 4-hydroxy-3-nitro-phenacetyl (NP) and can, when crosslinked by antigen, trigger the degranulation of human basophils. When not crosslinked, however, the chimaeric IgE can prevent the passive sensitization of these cells by sera from allergic subjects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Möller, G. (ed.) Immun. Rev. 41 (1978).

  2. Stanworth, D. R., Humphrey, J. H., Bennich, H. & Johansson, S. G. O. Lancet ii, 330–332 (1967).

    Article  Google Scholar 

  3. Oi, V. T., Morrison, S. L., Herzenberg, L. A. & Berg, P. Proc. natn. Acad. Sci. U.S.A. 80, 825–829 (1983).

    Article  ADS  CAS  Google Scholar 

  4. Neuberger, M. S. EMBO J. 2, 1373–1378 (1983).

    Article  CAS  Google Scholar 

  5. Ochi, T. et al. Proc. natn. Acad. Sci. U.S.A. 80, 6351–6355 (1983).

    Article  ADS  CAS  Google Scholar 

  6. Mulligan, R. C. & Berg, P. Proc. natn. Acad. Sci. U.S.A. 78, 2072–2076 (1983).

    Article  ADS  Google Scholar 

  7. Banerji, J., Olson, L. A. & Schaffner, W. Cell 33, 729–740 (1983).

    Article  CAS  Google Scholar 

  8. Gillies, S. D., Morrison, S. L., Oi, V. T. & Tonegawa, S. Cell 33, 717–728 (1983).

    Article  CAS  Google Scholar 

  9. Neuberger, M. S., Williams, G. T. & Fox, R. O. Nature 312, 604–608 (1984).

    Article  ADS  CAS  Google Scholar 

  10. Johansson, S. G. O. & Bennich, H. Immunology 13, 381 (1967).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Lichtenstein, L. M. & Osler, A. G. J. exp. Med. 120, 507–530 (1964).

    Article  CAS  Google Scholar 

  12. Ennis, M. Ag. Actions 12, 60–63 (1982).

    Article  CAS  Google Scholar 

  13. Chapman, M. D. & Platts-Mills, T. A. E. J. Immun. 125, 587–592 (1980).

    CAS  PubMed  Google Scholar 

  14. Flanagan, J. G. & Rabbitts, T. H. EMBO J. 1, 655–660 (1982).

    Article  CAS  Google Scholar 

  15. Morrison, S. L., Johnson, M. J., Herzenberg, L. A. & Oi, V. T. Proc. natn. Acad. Sci. U.S.A. 81, 6851–6855 (1984).

    Article  ADS  CAS  Google Scholar 

  16. Boulianne, G. L., Hozumi, N. & Shulman, M. J. Nature 312, 643–646 (1984).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Neuberger, M., Williams, G., Mitchell, E. et al. A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature 314, 268–270 (1985). https://doi.org/10.1038/314268a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/314268a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing